NCT06035757 2026-03-03
The Occurrence of Emergence Agitation in Pediatric Strabismus Surgery
Konkuk University Medical Center
Phase 4 Recruiting
Clinical Trials
60 trialsNCT06289673 2026-03-03
Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
St. Jude Children's Research Hospital
Phase 4 Recruiting
NCT07320534 2026-01-08
Levofloxacin Prophylaxis to Prevent First Febrile Neutropenia in Pediatric ALL During Induction Phase
Gadjah Mada University
Phase 4 Not yet recruiting
NCT05687032 2025-12-03
A Study of Inotuzumab Ozogamicin in Chinese Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
Pfizer
Phase 4 Completed
NCT07016165 2025-08-22
Ciprofloxacin vs Ceftazidime for Empirical Treatment of High-Risk Neutropenic Fever in Children With Hematologic Malignancies
Gadjah Mada University
Phase 4 Recruiting
NCT04506086 2025-05-18
Feasibility Study to Evaluate Outpatient Blinatumomab in Subjects With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL)
Amgen
Phase 4 Terminated
NCT05071482 2025-05-01
Flumatinib Versus Imatinib Combined With Chemotherapy for de Novo Ph+ ALL
Institute of Hematology & Blood Diseases Hospital, China
Phase 4 Terminated
NCT06918054 2025-04-09
Hepatoprotective for Children and Adolescent With Acute Lymphoblastic Leukemia
Ain Shams University
Phase 4 Recruiting
NCT06918080 2025-04-09
Hepatoprotective Measures for Children at High Risk of NAFLD
Ain Shams University
Phase 4 Active not recruiting
NCT06711679 2024-12-02
Exploring the Minimum Effective Concentration and Volume of Ropivacaine for Sacral Plexus Anesthesia
Tongji Hospital
Phase 4 Enrolling by invitation
NCT05784844 2024-09-19
Antimicrobial Revision in Persistent Febrile Neutropenia
Wake Forest University Health Sciences
Phase 4 Withdrawn
NCT06410833 2024-05-16
BRRPJS
Peking Union Medical College Hospital
Phase 4 Recruiting
NCT04846855 2024-02-12
RATAPED
Ramsay Générale de Santé
Phase 4 Completed
NCT01735955 2024-02-08
Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study
Novartis
Phase 4 Completed
NCT03677596 2023-11-22
A Study Of Two Inotuzumab Ozogamicin Doses in Relapsed/ Refractory Acute Lymphoblastic Leukemia Transplant Eligible Patients
Pfizer
Phase 4 Completed
NCT03043430 2023-04-25
Intranasal Ketamine for Anxiolysis in Pediatric Emergency Department Patients
Brooke Army Medical Center
Phase 4 Terminated
NCT00198978 2023-03-20
German Multicenter Trial for Treatment of Elderly Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Goethe University
Phase 4 Completed
NCT00199056 2023-03-20
German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (06/99)
Goethe University
Phase 4 Completed
NCT00199095 2023-03-20
Treatment of Elderly Patients (>65 Years) With Acute Lymphoblastic Leukemia
Goethe University
Phase 4 Completed
NCT00199069 2023-03-17
German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (05/93)
Goethe University
Phase 4 Completed
NCT03318393 2023-01-31
Study Comparing Bivalirudin Versus Heparin in Neonatal and Pediatric ECMO
University of Texas Southwestern Medical Center
Phase 4 Completed
NCT05682131 2023-01-12
SCCCG-R-ALL
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 4 Recruiting
NCT05611086 2022-11-09
N-Acetylcysteine vs Placebo as Adjunctive Treatment in Pediatric Leukemia
Dr Cipto Mangunkusumo General Hospital
Phase 4 Terminated
NCT00199082 2022-08-19
Newly Diagnosed Mature B-ALL, Burkitt's Lymphoma and Other High-grade Lymphoma in Adults
Goethe University
Phase 4 Completed
NCT00198991 2022-08-18
German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003)
Goethe University
Phase 4 Completed
NCT02447718 2022-06-24
Vaccinating Children After Chemotherapy
Canadian Immunization Research Network
Phase 4 Completed
NCT05340985 2022-04-22
Investigating the Effects of Hydroxyvitamin D3 on Multiple Sclerosis
Tehran University of Medical Sciences
Phase 4 Unknown
NCT01358201 2022-01-19
PETHEMA LAL-07FRAIL: All Treatment In Fragile Patients Ph' Negative Over 55 Years
PETHEMA Foundation
Phase 4 Unknown
NCT01366898 2022-01-19
Protocol For the Treatment Acute Lymphoblastic Leukemia With Ph 'Negative in Elderly Patients (> 55 Years)
PETHEMA Foundation
Phase 4 Unknown
NCT05137860 2022-01-18
Efficacy of the Use of Bortezomib for the Treatment of Relapsed Leukemia or Positive MRD
Hospital General de Mexico
Phase 4 Unknown
NCT05133310 2022-01-04
Effect of Simvastatin on Sepsis and Febrile Neutropenia in Patients With Acute Lymphoblastic Leukemia
Hospital General de Mexico
Phase 4 Unknown
NCT05176119 2022-01-04
Nalbuphine Versus Ketamine for Prevention of Emergence Agitation After Sevoflurane in Children Undergoing Tonsillectomy
Ain Shams University
Phase 4 Completed
NCT03176849 2020-11-17
A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 in Pediatric Patients Undergoing HSCT
Phoenix Children's Hospital
Phase 4 Completed
NCT00853008 2020-04-07
LAL-AR/2003
PETHEMA Foundation
Phase 4 Completed
NCT00003398 2019-10-17
Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
University of Maryland, Baltimore
Phase 4 Completed
NCT03369847 2019-07-18
Inhaled Steroids for Pediatric Asthma at Pediatric Emergency Medicine Discharge
New York City Health and Hospitals Corporation
Phase 4 Completed
NCT03920813 2019-04-23
Determinants of Mercaptopurine Toxicity in Paediatric Acute Lymphoblastic Leukemia Maintenance Therapy
Shandong University
Phase 4 Unknown
NCT02670564 2019-04-16
ALL SCTped FORUM - Pharmacogenomic Study (add-on Study)
Swiss Pediatric Oncology Group
Phase 4 Recruiting
NCT02933333 2018-10-17
G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Phase 4 Unknown
NCT01906671 2018-04-20
Study on Two Different Formulations of 6-mercaptopurine. Tablet Versus Oral Liquid
Rigshospitalet, Denmark
Phase 4 Unknown
NCT00576472 2017-05-30
Learning Impairments Among Survivors of Childhood Cancer
St. Jude Children's Research Hospital
Phase 4 Completed
NCT02953730 2016-11-03
The Study on the Pharmacokinetics of PEG-rhG-CSF in Children and Adolescents
ChineseAMS
Phase 4 Completed
NCT02938741 2016-10-25
ATG Based Conditioning Regimen in HLA Related HSCT for Aggressive T-cell Tumors
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 4 Unknown
NCT02894645 2016-09-30
Malaysia-Singapore Acute Lymphoblastic Leukemia 2010 Study
National University Hospital, Singapore
Phase 4 Unknown
NCT00526175 2016-01-20
LAL-BR/2001: Study Treatment to Low Risk ALL
PETHEMA Foundation
Phase 4 Completed
NCT01873807 2015-10-09
HITA
Nanfang Hospital, Southern Medical University
Phase 4 Unknown
NCT02049255 2014-11-03
Comparision of the Use in Marcaine and Chloroprocaine in Rachianesthesia for the Surgical Correction of Inguinal Hernia.
Astes
Phase 4 Completed
NCT00526409 2014-10-28
LAL-AR-N-2005
PETHEMA Foundation
Phase 4 Completed
NCT01358253 2014-05-20
Rituximab Plus Chemotherapy for CD20+ Adult Acute Lymphoblastic Leukemia
Ruijin Hospital
Phase 4 Completed
NCT01990807 2013-11-21
Treatment Protocol of Children With Philadelphia Chromosome Negative High Risk Acute Lymphoblastic Leukemia
ChineseAMS
Phase 4 Unknown